DavosPharma competitorsClear all

DavosPharma's top competitors include Innovus Pharmaceuticals, GT Biopharma, Emisphere Technologies and Portola Pharmaceuticals.
DavosPharma
DavosPharma
DavosPharma is a company providing discovery, chemistry, and formulation services.
Innovus Pharmaceuticals
Innovus Pharmaceuticals
Innovus Pharmaceuticals is an emerging pharmaceutical company that develops, in-licenses, acquires and markets proprietary pharmaceutical products with unique packaging and presentation for better patient compliance and results.
GT Biopharma
GT Biopharma
GT Biopharma (formerly Oxis International) is engaged in the development of immunotherapies for cancer treatment.
Emisphere Technologies
Emisphere Technologies
Emisphere Technologies is a commercial-stage pharmaceutical and drug delivery company.
Portola Pharmaceuticals
Portola Pharmaceuticals
Portola Pharmaceuticals is a biopharmaceutical company.
Founding Date
Founding Date
1972
Founding Date
2011
Founding Date
1965
Founding Date
1986
Founding Date
2003
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Upper Saddle River, US HQ
Locations
San Diego, US HQ
Englewood, US
Locations
Tampa, US HQ
Beverly Hills, US
Locations
Roseland, US HQ
Locations
South San Francisco, US HQ
Krailling, DE
Amsterdam, NL
Employees
Employees
19
Employees
1814% decrease
Employees
340% decrease
Employees
650% decrease
Employees
32429% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
3.4 m
Valuation ($)
10 m
Valuation ($)
494.3 m
Valuation ($)
1.4 b
Twitter followers
Twitter followers
1.1 k
Twitter followers
27.3 k
Twitter followers
66
Twitter followers
446
Twitter followers
951
Alexa Website Rank
Alexa Website Rank
335014
Alexa Website Rank
295671
Alexa Website Rank
379858
Alexa Website Rank
317476
Alexa Website Rank
501399
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
2
Employee Rating
3.5

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$24m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$1.2m (FY, 2016)
Revenue (est.)
$116.6m (FY, 2019)
Cost of goods
Cost of goods
N/A
Cost of goods
$4.3m (FY, 2018)
Cost of goods
N/A
Cost of goods
$286k (FY, 2016)
Cost of goods
$44.4m (FY, 2019)
Gross profit
Gross profit
N/A
Gross profit
$19.7m (FY, 2018)
Gross profit
N/A
Gross profit
$909k (FY, 2016)
Gross profit
$72.3m (FY, 2019)
Net income
Net income
N/A
Net income
($8.3m) (FY, 2018)
Net income
($38.6m) (FY, 2019)
Net income
($10m) (FY, 2016)
Net income
($290.7m) (FY, 2019)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 1.4m
Total funding raised
N/A
Total funding raised
$ 295.1m
For sources of this data, please see the company profile

View company profiles

Innovus Pharmaceuticals
HQ
San Diego, US
Employees
18↓ 14% decrease

Innovus Pharmaceuticals is an emerging pharmaceutical company that develops, in-licenses, acquires and markets proprietary pharmaceutical products with unique packaging and presentation for better patient compliance and results.

View company
GT Biopharma
HQ
Tampa, US
Employees
3↓ 40% decrease

GT Biopharma (formerly Oxis International) is engaged in the development of immunotherapies for cancer treatment.

View company
Emisphere Technologies
HQ
Roseland, US
Employees
6↓ 50% decrease

Emisphere Technologies is a commercial-stage pharmaceutical and drug delivery company.

View company
Portola Pharmaceuticals
HQ
South San Francisco, US
Employees
324↑ 29% increase

Portola Pharmaceuticals is a biopharmaceutical company.

View company